Connect with us on October 5 from 3-4.15 p.m. for the second webinar in the series examining the results of the FIGARO-DKD study and assessing its implications for clinical practice in nephrology and cardiology: Amplification of the presentation of the main results of the FIGARO trial Join Speakers Gerasimos Filippatos, Greece, Javed Butler, USA, and Adeera...
Join the latest #NephTrials discussion on September 28, 2021, at 9 p.m. EST. The conversation will focus on Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), which evaluates if spironolactone reduces heart failure and heart-related deaths in dialysis patients. The #NephTrials initiative is an exciting series of conversations combining expertise from the ISN-ACT...
The ISN and the Mario Negri Institute for Pharmacological Research will hold the first of two webinars on September 17, 2021, at 2 p.m. CEST on: “New Insights into Clinical Management of Complement-mediated Thrombotic Microangiopathies” The webinar will address: Identifying patients with complement-mediated TMA The impact of genetic and biochemical characterization Treatment recommendations Clinical perspectives of emerging complement inhibitors Register for...
Fluid removal is a principal component of the kidney replacement therapy (KRT) prescription. However, there is a lack of high-quality evidence to guide fluid balance management in this context. The Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Canada, is conducting a survey to learn more about the attitudes and practice patterns of intensivists and nephrologists...
Roberto Picoits-Filho and Smeeta Sinha talk to Michael G. Shlipak, University of California, San Francisco, and Sri Lekha Tummalapalli, Weill Cornell Medicine, about the KDIGO Controversies Conference and the resulting ISN-KDIGO Chronic Kidney Disease (CKD) Early Identification and Intervention Toolkit. Listen to the Podcast Drs. Tummalapali and Shlipak discuss current screening recommendations, testing, and treatment for...
The #NephTrials initiative is an exciting series of conversations combining expertise from: The ISN-ACT Global Trials Focus The ISN-ACT Toolkit The #NephJC community Join us on September 28, 2021, at 9 p.m. EST to discuss: Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), evaluating if spironolactone reduces heart failure and heart-related deaths in dialysis patients. — Discussion focus: Run-in periods: useful or threat...
Connect to the first webinar on September 7, 2021, from 3 - 4.15 p. m. CEST Register here. Prevention and treatment of DKD are critical to the future of global kidney health. Previously, the use of MRA in DKD has been limited by its adverse side effects. The development of non-steroidal MRAs seeks to optimize DKD treatment...
The ISN Framework for Developing Dialysis Programs in Low-Resource Settings is now available on the World Health Organization's NCD webpage. The framework, launched at the Global Policy Kidney Forum, ensures equal access to quality dialysis for kidney failure patients around the globe, as outlined in this article in The Lancet. The ISN encourages all to download...
The paper, “Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey,” has been published in BMJ Open. Read the paper here. The ISN GKHA is a worldwide survey to assess the current capacity for kidney care. Designed to document the availability of the six principles* of Universal Health Coverage...
From the ISN i3C (International Consortium CKDu Collaborators) network: A series of innovative digital activities to guide nephrologists and healthcare leaders on implementing a kidney biopsy program. The activities include webinars, educational videos, and two audio interviews on the ISN Academy. Access here. The ISN Observatory of CKDu facilitates data sharing and collaboration between the diverse...
To facilitate understanding of important clinical trial methodologies, the ISN-ACT Clinical Trials Toolkit subgroup members are producing a series of stories based on various ISN-ACT Clinical Trials Toolkit topics. The second of these narratives outlines several trial design methods through fictional clinical discussions. Access chapter two here. The ISN-ACT Clinical Trials Toolkit is a comprehensive step-by-step...
BMC Nephrology has published a paper on coding practice in national and regional kidney biopsy registries. The paper gives an overview of kidney biopsy registries, explores how kidney diseases are coded, and demonstrates the need to improve coding practice. This is the first publication from the Kidney Biopsy Codes for pathologists project, which aims to provide...
Access user-friendly guides, infographics, teaching tools, articles, and webinars to assist early identification and intervention of chronic kidney diseases. Look out for additional open-access tools in 2021, including regional-specific materials, PCP- and AHP- specific materials, and a podcast. Discover the Toolkit
The Kidney International Reports' (KIR) Jai Radhakrishnan, editor-in-chief, Sumit Mohan, deputy editor, and Radha McLean, executive editor, highlight the journal's significant role in disseminating valuable research in nephrology, having published over 1,000 articles since its launch in 2016. The article, 5 Years (And Counting) of Expanding Access to Kidney Disease Research, marking the fifth anniversary...
In October 2020, Kidney International published the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020 developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, earlier that year. The paper has been summarized into a slide deck and user guide for...
In 2018, Amarasiri de Silva (Sri Lanka/USA) received an ISN-H4KH (Hydration for Kidney Health) Fellowship Grant. His abstract, "POS-314 People’s knowledge of Chronic Kidney Disease of Unknown Etiology in Sri Lanka," was accepted for presentation at WCN21 and published in Kidney International Reports. Amarasiri de Silva investigated a Sri Lankan population's knowledge of CKDu, and their...
An updated edition of the ISN-ACT Clinical Trials Toolkit is now available. It includes additional content and new resources. The Toolkit was updated and improved based on feedback from the ISN-ACT Toolkit subgroup and the nephrology community. The Toolkit is an ISN open-access, online resource to guide trial design, study conduct, data management, data analysis, and publications....
The ISN Webinar, Dissemination and Implementation of Therapies for Kidney Diseases in Low- and High-Income Countries, will be broadcast on Thursday, April 29, at 3 p.m. CEST (convert to your time zone here). Register here. SGLT2i inhibitors protect the heart and the kidney, but equitable access to these and other drugs for Chronic Kidney Disease and...
The objective of the ISN Global Kidney Health Atlas (GKHA) is to provide a snapshot of individual country and regional health system characteristics, as well as specific elements relevant to the management of patients with kidney failure in terms of the WHO health systems building blocks. Our collection of manuscripts from the ten ISN regions,...
The ISN i3C (International Consortium CKDu Collaborators) group has redesigned the ISN Observatory of CKDu map. Access the map and share your data here. The map facilitates collaboration and data exchange to raise awareness of the urgent issue of chronic kidney disease of unknown etiology (CKDu). This initiative was developed as part of ISN’s 2018-2020 Collaboration Plan...
